435 related articles for article (PubMed ID: 11785696)
41. Biodegradable polymerized simvastatin stimulates bone formation.
Venkatesan N; Liyanage ADT; Castro-Núñez J; Asafo-Adjei T; Cunningham LL; Dziubla TD; Puleo DA
Acta Biomater; 2019 Jul; 93():192-199. PubMed ID: 31055123
[TBL] [Abstract][Full Text] [Related]
42. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model.
Kokubo S; Fujimoto R; Yokota S; Fukushima S; Nozaki K; Takahashi K; Miyata K
Biomaterials; 2003 Apr; 24(9):1643-51. PubMed ID: 12559824
[TBL] [Abstract][Full Text] [Related]
43. Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect.
Li L; Zhou G; Wang Y; Yang G; Ding S; Zhou S
Biomaterials; 2015 Jan; 37():218-29. PubMed ID: 25453952
[TBL] [Abstract][Full Text] [Related]
44. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
45. Dual delivery of encapsulated BM-MSCs and BMP-2 improves osteogenic differentiation and new bone formation.
Kong Y; Zhao Y; Li D; Shen H; Yan M
J Biomed Mater Res A; 2019 Oct; 107(10):2282-2295. PubMed ID: 31152570
[TBL] [Abstract][Full Text] [Related]
46. N-methyl pyrrolidone/bone morphogenetic protein-2 double delivery with in situ forming implants.
Karfeld-Sulzer LS; Ghayor C; Siegenthaler B; de Wild M; Leroux JC; Weber FE
J Control Release; 2015 Apr; 203():181-8. PubMed ID: 25697800
[TBL] [Abstract][Full Text] [Related]
47. Multilayered pore-closed PLGA microsphere delivering OGP and BMP-2 in sequential release patterns for the facilitation of BMSCs osteogenic differentiation.
Zhang BJ; Han ZW; Duan K; Mu YD; Weng J
J Biomed Mater Res A; 2018 Jan; 106(1):95-105. PubMed ID: 28884494
[TBL] [Abstract][Full Text] [Related]
48. Injectable BMP-2 delivery system based on collagen-derived microspheres and alginate induced bone formation in a time- and dose-dependent manner.
Mumcuoglu D; Fahmy-Garcia S; Ridwan Y; Nicke J; Farrell E; Kluijtmans SG; van Osch GJ
Eur Cell Mater; 2018 Apr; 35():242-254. PubMed ID: 29697853
[TBL] [Abstract][Full Text] [Related]
49. Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres.
Weber FE; Eyrich G; Grätz KW; Maly FE; Sailer HF
Int J Oral Maxillofac Surg; 2002 Feb; 31(1):60-5. PubMed ID: 11936402
[TBL] [Abstract][Full Text] [Related]
50. Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit.
Meikle MC; Papaioannou S; Ratledge TJ; Speight PM; Watt-Smith SR; Hill PA; Reynolds JJ
Biomaterials; 1994 Jun; 15(7):513-21. PubMed ID: 7918904
[TBL] [Abstract][Full Text] [Related]
51. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
52. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
[TBL] [Abstract][Full Text] [Related]
53. BMP-2-releasing gelatin microspheres/PLGA scaffolds for bone repairment of X-ray-radiated rabbit radius defects.
Xia P; Wang S; Qi Z; Zhang W; Sun Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1662-1673. PubMed ID: 31032645
[TBL] [Abstract][Full Text] [Related]
54. Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release.
Schrier JA; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(3):E17. PubMed ID: 14727876
[TBL] [Abstract][Full Text] [Related]
55. Local BMP-7 release from a PLGA scaffolding-matrix for the repair of osteochondral defects in rabbits.
Jung MR; Shim IK; Chung HJ; Lee HR; Park YJ; Lee MC; Yang YI; Do SH; Lee SJ
J Control Release; 2012 Sep; 162(3):485-91. PubMed ID: 22902517
[TBL] [Abstract][Full Text] [Related]
56. Injectable PLGA microspheres with tunable magnesium ion release for promoting bone regeneration.
Yuan Z; Wei P; Huang Y; Zhang W; Chen F; Zhang X; Mao J; Chen D; Cai Q; Yang X
Acta Biomater; 2019 Feb; 85():294-309. PubMed ID: 30553873
[TBL] [Abstract][Full Text] [Related]
57. Bone induction and bone repair by composites of bone morphogenetic protein and biodegradable synthetic polymers.
Miyamoto S; Takaoka K
Ann Chir Gynaecol Suppl; 1993; 207():69-75. PubMed ID: 8154840
[TBL] [Abstract][Full Text] [Related]
58. Use of a bioactive scaffold for the repair of bone defects in a novel reproducible vertebral body defect model.
Liang H; Wang K; Shimer AL; Li X; Balian G; Shen FH
Bone; 2010 Aug; 47(2):197-204. PubMed ID: 20580872
[TBL] [Abstract][Full Text] [Related]
59. Effect of recombinant human bone morphogenetic protein-2 on bone formation in alveolar ridge defects in dogs.
Nagao H; Tachikawa N; Miki T; Oda M; Mori M; Takahashi K; Enomoto S
Int J Oral Maxillofac Surg; 2002 Feb; 31(1):66-72. PubMed ID: 11936403
[TBL] [Abstract][Full Text] [Related]
60. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
